Leptin and the gastrointestinal tract

Current Opinion in Gastroenterology

Volumn 16, Issue 2, 2000, Pages 160-165

  Raguso, Camasio ^a   McCullough, Arthur J ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012559672     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200003000-00011     Document Type: Article

References (57)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
2. Friedman JM: Leptin, leptin receptor and the control of body weight. Nutr Rev 1998, 56:538-346.
3. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
4. Morton NM, Emilsson V, Liu YL, Cawthorne MA: Leptin action in intestinal cells. J Biol Chem 1998, 273:26194-26201. This study identified the presence of the leptin receptor in the jejunum.
5. O'Doherty RM, Anderson PR, Zhao AZ, Bornfeldt KE, Newgard CB: Sparing effect of leptin on glycogen stores in rats during the fed -to-fast transition. Am J Physiol 1999, 277:E544-E550.
6. Aiston S, Agius L: Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin. Diabetes 1999, 48:15-20.
7. Zhou YT, Shimabukuro M, Koyama K, Lee K, Wang F, Trieu CB, Newgard, Under RU: Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci USA 1997, 94:6386-6390.
8. Seeley RJ, Van Dijk G, Campfield LA, Smith FJ, Burn P, Nelligan JA, et al.: Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res 1996, 28:664-668.
9. Banks WA, Kastin AJ, Huang W, Jaspin JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
10. Tartaglia LA, Demski M, Weng X, Deng N, Culpepper J, Devos R, et al.: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1-20.
11. Kotz CM, Briggs JE, Pomonis JD, Grace MK, Levine AS, Billington CJ: Neural site of leptin influence on neuropeptide Y signaling ways altering feeding and uncoupling protein. Am J Physiol 1998, 275:R478-R484. This study implicated neuropeptide Y as the mechanism of leptin-induced satiety. It also demonstrated that leptin has an effect on uncoupling proteins.
12. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, et al.: Evidence of free and bound leptin in human circulation: studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996, 98:1277-1282.
13. Scholz GH, Englaro P, Thiele I, Scholz M, Klusman T, Kellner K, et al.: Dissociation of serum leptin concentration and body fat content during long-term dietary intervention in obese individuals. Horm Metab Res 1996, 28:718-723.
14. DeMarinis L, Mucini A, Valle D, Bidnchi A, Milaroli D, Proto A: Plasma leptin levels after biliopancreatic diversion: dissociation with body mass index. J Clin Endocrinol Metab 1999, 84:2386-2389. This study, together with reference 23, emphasizes that the anatomy of the gastrointestinal tract is an important factor in determining serum leptin levels.
15. Bado A, Levasaseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, et al.: The stomach is a source of leptin. Nature 1998, 394:790-793. This study, together with references 18 and 19, demonstrated that leptin and its receptor are present in fundic epithelium in the stomach and are regulated by gastrointestinal hormones.
16. Wang YH, Tache Y, Sheibel AB, Go VL, Wei JY: Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats. Am J Physiol 1997, 273:R833-R837.
17. Nemecz M, Preininger K, Englisch R, Furnsinn C, Schneider B, Waldhausl W, Roden M: Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused rat liver. Hepatology 1999, 29:166-172.
18. Mix H, Manns MP, Wagner S, Widjaja A, Brabant G: Expression of leptin and its receptor in the human stomach (letter). Gastroenterology 1999, 117:509. See [15•].
19. Attoub S, Levasseur S, Buyse M, Goiot H, Laigneau JP, Moizo L, et al.: Physiological role of cholecystokinin B/gastrin receptor in leptin secretion. Endocrinology 1999,140:4406-4410. See [15•].
20. VanDijk G, Seeley RJ, Thiele TE, Friedman MI, Ji H, Wilkinson CW, et al.: Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat. Am J Physiol 1999, 276:R1425-R1433. This study suggests that leptin may act locally to decrease gastric emptying and consequently induce satiety via a noncentral mechanism.
21. Schoeller DA, Cella LK, Sinha MK, Caro JF: Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 1997, 100:1882-1887.
22. Havel PJ, Townsend R, Chaump L, Teff K: High-fat meals reduce 24-hour circulating leptin concentrations in women. Diabetes 1999, 48:334-341.
23. Levy JR, Heuman DM, Pandak WM, Stevens W: Effect of bile acid composition and manipulation of enterohepatic circulation on leptin gene regulation. Metabolism 1998,47:285-291. See [14•].
24. LeGall-Salmon E, Stevens WD, Levy JR: Total parenteral nutrition increases serum leptin concentration in hospitalized undernourished patients. JPEN 1999, 23:38-42.
25. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Duda A, Pierzchalski P, et al.: Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide. Eur J Pharmacol 1999, 374:263-276. See [26•].
26. Smith PM, Mollaret V, Feruson AV: Leptin acts in the rat hypothalamic paraventricular nucleus to induce gastric mucosal damage. Am J Physiol 1998, 275:R2081-R2084. References 25 and 26 suggest that leptin may influence gastric mucosal integrity via a neural mechanism.
27. Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG, Tartaglia LA, Baumann H: Leptin receptor action in hepatic cells. J Biol Chem 1997, 272:16216-16223.
28. Burcelin R, Kamohra S, Li J, Tannenbaum GS, Charron MJ, Friedman JM: Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 1999, 48:1264-1269. See [31•].
29. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996, 274:1185-1188.
30. Rossetti L, Massillon D, Barzilai N, Vuquin P, Chen W, Hawkins M, Wu J: Short-term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 1997, 272:27758-27763.
31. 13C NMR study of the effects of leptin treatment on kinetics of hepatic intermediary metabolism. Proc Natl Acad Sci 1998, 95:7385-7390. These references [28, 30] emphasize the potentially important role that leptin plays in hepatic substrate metabolism.
32. Flier JS: Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci USA 1997, 94:4242-4245.
33. Linger RH, Zhou YT, Orci L: Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci USA 1999, 96:2327-2332.
34. Lopez-Soriano J, Carbo N, Lopez-Soriano J, Argiles JM: Short-term effects of leptin on lipid metabolism in the rat. FEBS Lett 1998, 431:371-274.
35. Shimabukuro M, Koyama K, Chen G, Wang MY, Trier F, Lee Y, Newgard CB: Direct anti-diabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997, 94:4637-4641.
36. Kaplan LM: Leptin, obesity and liver disease. Gastroenterology 1998, 115:997-1001.
37. Silver DL, Jiang XC, Tall AR: Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. J Biol Chem 1999, 274:4140-4146.
38. Liao W, Angelin B, Rudling M: Lipoprotein metabolism in the fat Zucker rat: reduced basal expression but normal regulation of hepatic low density lipoprotein receptors. Endocrinology 1997, 138:3276-3282.
39. Halle M, Berg A, Garwers U, Grathwohl D, Knisel W, Keul J: Concurrent reductions of serum leptin and lipids during weight loss in obese men with type 11 diabetes. Am J Physiol 1999, 40:E277-E282.
40. McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC: Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998, 115:947-953. See [41•].
41. Henrikson H, Holst JJ, Moller S, Brinch K, Bendtsen F: Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatology 1999, 29:1818-1824. These two studies [40, 41] demonstrate that serum leptin is increased disprortionately to fat mass in alcoholic cirrhosis and suggest the possibility that leptin may be involved in the anorexia that occurs in this disease.
42. Jensen MD, Moller N, Sreekumaran K, Eisenberg P, Landt M, Klein S: Regional leptin kinetics in humans. Am J Clin Nutr 1999, 69:18-21.
43. Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Feingold KR: Endotoxin and cytokines induce expression of leptin the OB gene product, in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 1996, 97:2152-2157.
44. Zumback MS, Boehme MWJ, Wahl P: Tumor necrosis factor increases serum leptin levels in humans. Clin Endocrinol and Metab 1997, 82:4080-4082.
45. Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R: Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology 1999, 46:2422-2425. See [46•].
46. Watson AM, Poloyac SM, Howard G, Blouin RA: Effect of leptin on cytochrome P-450, conjugation and antioxidant enzymes in the ob/ob mouse. Drug Metabolism & Disposition 1999, 27:695-700. Reference 46 indicates that leptin decreases the antioxidant capacity of liver cells, and when considered with Reference 45 it suggests that leptin may play an important role in the pathophysiology of fatty liver disease.
47. Fehmann HC, Peiser C, Bode HP, Stamm M, Staats P, Hedetoft C, et al.: Leptin: a potent inhibitor of insulin secretion. Peptides 1997, 18:1267-1273.
48. Emilson V, Liu Y, Cawthorne MA, Morton NM, Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action on insulin secretion. Diabetes 1997, 46:313-316.
49. Mizuno A, Murakami T, Otani S, Kuwajima M, Shima K: Leptin affects pancreatic endocrine functions through the sympathetic nervous system. Endocrinology 1998, 139:3863-3870.
50. Kieffer TJ, Heller RS, Leech CA, Holz GG, Habener JF: Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic β-cells. Diabetes 1997, 46:1087-1093.
51. Kieffer TJ, Heller RS, Habener JF: Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 1998, 224:522-527. This reference, as well as references 52 and 53, demonstrate the presence of leptin receptors in pancreatic beta-cells and suggest that leptin might be involved in the adipogenic diabetes mellitus associated with obesity.
52. Seuffert J, Kieffer TJ, Habener JF: Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 1999, 96:674-679. See [51•].
53. Seufert J, Kieffer TJ, Leech CA, Holz GG, Moritz W, et al.: Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenio diabetes mellitus. J Clin Endocrinol Metab 1999,84:670-676. See [51•].
54. Harris DM, Flannigan KL, Go VL, Wu SV: Regulation of cholecystokinin-mediated amylase secretion by leptin in rat pancreatic acinar tumor cell line AR42J. Pancreas 1999, 19:224-230. This study demonstrates that leptin may influence the pancreatic acinar function in addition to islet cell function.
55. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Linger RH: Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 1994, 91:10878-10882.
56. Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced b-cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998, 95:2498-2502.
57. Koyama K, Chen G, Wang MT, Lee Y, Shimabukuro M, Newgard CB, Unger RH: β-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 1997, 46:1276-1280.